• LinkedIn
  • Twitter
  • Facebook
  • Careers
  • Contact Us
  • Press & Media
  • Swedish
  • English English English en
  • Svenska Svenska Swedish sv
Spermosens ABSpermosens logo
  • Technology
  • Team
    • Board
  • Investors
    • IPO 2021
  • About us
    • Milestones
    • Sponsorships & Memberships
    • Sustainable Development Goals
  • ART Academy
  • Menu Menu

Your ideal partner in IVF

World leading developer of Male-Factor Infertility Diagnostics.

The Technology
Latest news
All/Articles/Pressreleases
Newborn child on soft blankets
16 April, 2021

Spermosens erhåller preliminärt patentgodkännande från Europapatentverket

15 April, 2021

Kommentar från styrelsen i Spermosens angående tilldelning av units

Couple on blanket
14 April, 2021

Kallelse till årsstämma i Spermosens AB (publ)

6 April, 2021

Spermosens förbereder inför marknadslansering med nyemission

26 March, 2021

Ophelia Invest: 60 millioner par i verden kæmper med infertilitet – Spermosens kan hjælpe

23 March, 2021

Rapidus: Spermaforskning till börsen

Newborn child on soft blankets
16 April, 2021

Spermosens erhåller preliminärt patentgodkännande från Europapatentverket

15 April, 2021

Kommentar från styrelsen i Spermosens angående tilldelning av units

Couple on blanket
14 April, 2021

Kallelse till årsstämma i Spermosens AB (publ)

A
Revolutionary
Diagnostic
Tool

A
Revolutionary
Diagnostic
Tool

Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment.

It has not been possible to predict if the sperms can actually fertilize the oocyte (egg cell). The diagnostics have relied on sperms’ physical properties and motility, thus directing the majority of treatments to the highly invasive and unnecessary ICSI, instead of the safer and more natural standard-IVF.

This all changes now

Male Infertility

15% of the couples are globally affected by infertility, with male-factor accounting for 50% of the global infertility.

Unfortunately, there has been little progress in methods to diagnose male-factor infertility, and 40% of these cases remain unexplained.

Spermosens aims to empower caregivers and patients alike, helping to understand the cause of male-factor infertility despite seemingly normal sperms.

15%

GLOBAL INFERTILITY
50% MALE

50%

DECREASE IN SPERM COUNT SINCE 1970S

40%

UNEXPLAINED MALE INFERTILITY

2.4M

IVF CYCLES PERFORMED ANNUALLY

20%

SUCCESS RATES

The Answer

Spermosens’ patent-pending technology is based on the 2014 discovery of the JUNO protein, and has emanated in a user friendly and small footprint diagnostic system which in 30 minutes predicts the fusion capacity of the sperms.

Breakthrough Platform technology

This will lead to an immediate decision if the sperm sample is suitable for standard-IVF or ICSI, thus drastically limiting the number of cycles required for fertilisation and reducing the burden of infertility on the female partner.

Millions of couples waiting in queue for 1-3 years for IVF can now be helped quicker and more economically.

Read more

SIGN UP AND STAY CONNECTED

Get the latest news by signing up to our monthly newsletter. We welcome you to contact us with any thoughts you may have.

John Lempert
CEO

ART Academy

Assisted Reproductive Technology

  • Assisted Reproductive Technologies

    Assisted Reproductive Technologies, including Intrauterine Inseminations (IUI), In Vitro Fertlization (IVF), In Vitro Maturation (IVM) and Frozen Embryo Transfer (FET).

  • Reproductive System

    The Male and the Female Reproductive Systems.

  • Assisted Reproductive Technologies

    Assisted Reproductive Technologies, including Intrauterine Inseminations (IUI), In Vitro Fertlization (IVF), In Vitro Maturation (IVM) and Frozen Embryo Transfer (FET).

  • Reproductive System

    The Male Reproductive System and the Female Reproductive System.

  • Copulation to Conception

  • Infertility

    Methods used today to treat male and female infertility. The content is a description of commonly used infertility treatment technologies.

  • Infertility

    Methods used today to treat male and female infertility. The content is a description of commonly used infertility treatment technologies.

  • Copulation to Conception

    Fundamental steps to conception.

Learn more
Spermosens logo

Spermosens AB

MEDICON VILLAGE
Scheeletorget 1
223 81 Lund, Sweden

 

Legal notices

  • Privacy Policy
Cookie settings
© Copyright 2021 - Spermosens AB | Photos from Unsplash.com | Icons from Flaticon.com | Website by 8612 Hemsidesproduktion
  • LinkedIn
  • Twitter
  • Facebook
Scroll to top

This site uses cookies. Please accept the settings or adjust them to your personal preference.

Accept settingsHide this notificationSettings

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visit to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Privacy Policy
Accept settingsHide the notification
  • English
  • Swedish